Clinical Trials Browser

Phase 2 × Bone Diseases, Metabolic × Clear all

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Phase 2 Completed

60 enrolled

Genitourinary

Bone Diseases, Metabolic, Prostatic Neoplasms

Clinical Trials

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer